Trial intelligence / Profile preview

ISAR-CHOICE-2: Clopidogrel Maintenance Doses After PCI

NCT00140465Phase 4Completed

Sponsor
Deutsches Herzzentrum München
Start
Oct 2004
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of clopidogrel in coronary artery disease (CAD), sponsored by Deutsches Herzzentrum München. Started Oct 2004; status: completed.

02

Drugs

clopidogrel
03

Conditions

coronary artery disease (CAD)

Beyond the preview

Go deeper on NCT00140465.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00140465.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call